Enhancement of somatostatin-receptor-targeted 177Lu-[DOTA0-Tyr3]-octreotide therapy by gemcitabine pretreatment-mediated receptor uptake, up-regulation and cell cycle modulation-Reference-Cited by-同舟云学术

Enhancement of somatostatin-receptor-targeted 177Lu-[DOTA0-Tyr3]-octreotide therapy by gemcitabine pretreatment-mediated receptor uptake, up-regulation and cell cycle modulation

Published:2008-08 Issue:6 Volume:35 Page:673-678
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Nayak Tapan K.,Atcher Robert W.,Prossnitz Eric R.,Norenberg Jeffrey P.

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Molecular Medicine

Reference27 articles.

1. Peptide Receptor Radionuclide Therapy with radiolabelled somatostatin analogues in patients with somatostatin receptor positive tumours;Van Essen;Acta Oncol,2007

2. Peptide receptor radionuclide therapy;Krenning;Ann N Y Acad Sci,2004

3. Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors;Kwekkeboom;J Clin Oncology,2005

4. Yttrium-90 DOTATOC: first clinical results;Otte;Eur J Nucl Med,1999

5. Somatostatin-receptor-targeted alpha-emitting (213)Bi is therapeutically more effective than beta(−)-emitting (177)Lu in human pancreatic adenocarcinoma cells;Nayak;Nucl Med Biol,2007

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Enhancing [177Lu]Lu-DOTA-TATE therapeutic efficacy in vitro by combining it with metronomic chemotherapeutics;EJNMMI Research;2024-08-13

2. Graph Attention Networks for Drug Combination Discovery: Targeting Pancreatic Cancer Genes with RAIN Protocol;2024-02-28

3. [111In-DTPA0-D-Phe1]-Octreotide: The Ligand—The Receptor—The Label;Liver Intra-arterial PRRT with 111In-Octreotide;2021

4. Gemcitabine potentiates the anti-tumour effect of radiation on medullary thyroid cancer;PLOS ONE;2019-11-14

5. Combination treatments to enhance peptide receptor radionuclide therapy of neuroendocrine tumours;European Journal of Nuclear Medicine and Molecular Imaging;2019-09-06